Related Experiment Videos
Bioartificial pancreas research in Japan
Hiroo Iwata1, Hideki Simada, Eisai Fukuma
1Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. iwata@frontier.kyoto-u.ac.jp
Artificial Organs
|January 15, 2004
Summary
Researchers in Japan are developing bioartificial pancreases (BAPs) to physiologically control glucose levels in diabetic patients. This review highlights progress in BAP membrane technology and cell production for treating diabetes complications.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Endocrinology
Background:
- Diabetes mellitus poses significant health risks due to chronic hyperglycemia.
- Current diabetes management often fails to prevent long-term complications.
- The bioartificial pancreas (BAP) offers a potential solution for physiological glucose control.
Purpose of the Study:
- To review current research on bioartificial pancreas development in Japan.
- To outline advancements in BAP technology, including membrane preparation and cell sourcing.
- To identify challenges in producing insulin-secreting cells for BAP applications.
Main Methods:
- Review of Japanese research activities on bioartificial pancreas development.
- Analysis of membrane preparation techniques for BAP devices.
- Evaluation of in vitro and in vivo BAP functionality.
- Assessment of stem cell-derived insulin-secreting cell production.
Main Results:
- Significant progress in developing semipermeable membranes for BAP devices.
- Successful in vitro and in vivo functional evaluations of BAP prototypes.
- Identification of key challenges in generating sufficient insulin-secreting cells from stem cells.
Conclusions:
- The bioartificial pancreas holds promise for physiological glucose regulation in diabetes.
- Continued research in Japan is advancing BAP technology and cell production methods.
- Overcoming stem cell-derived cell production challenges is crucial for clinical translation.